Evidence map›Paper›PMID 24113819›Full record

ArticleJAMA ophthalmology2013

Classification of posterior polymorphous corneal dystrophy as a corneal ectatic disorder following confirmation of associated significant corneal steepening.

Anthony J Aldave, Lydia B Ann, Ricardo F Frausto, Catherine K Nguyen, Fei Yu, Irving M Raber

Open access · bronzeAbstract read
In one paragraph

Article in JAMA ophthalmology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 47 citations in OpenAlex.

  1. Posterior Polymorphous Corneal Dystrophy in a Patient with a NovelInternational journal of molecular sciences · 2022
    Article
  2. Update on the genetics of corneal endothelial dystrophies.Indian journal of ophthalmology · 2022
    Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. CUGC for posterior polymorphous corneal dystrophy (PPCD).European journal of human genetics : EJHG · 2020
    Article
  8. Article
  9. Article
  10. Alport Patients without Classic Ocular Symptoms Have Smaller Lens Diameter.Medical science monitor : international medical journal of experimental and clinical research · 2019
    Article
  11. Article
  12. Transcriptomic Profiling of Posterior Polymorphous Corneal Dystrophy.Investigative ophthalmology & visual science · 2017
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Anthony J AldaveJules Stein Eye Institute, David Geffen School of Medicine at University of California, Los Angeles.
Lydia B AnnJules Stein Eye Institute, David Geffen School of Medicine at University of California, Los Angeles.
Ricardo F FraustoJules Stein Eye Institute, David Geffen School of Medicine at University of California, Los Angeles.
Catherine K NguyenJules Stein Eye Institute, David Geffen School of Medicine at University of California, Los Angeles.
Fei YuJules Stein Eye Institute, David Geffen School of Medicine at University of California, Los Angeles.
Irving M RaberWills Eye Institute, Philadelphia, Pennsylvania.
University of California, Los Angeles · USDoheny Eye Institute · USWills Eye Hospital · US

Funding

Vision Research Core at UCLAP30EY000331 · NEI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Gregory Darin Field, DAVID S WILLIAMS · 1985 to 2026
$16.8M
Identification and Characterization of the Genetic Basis of PPCDR01EY022082 · NEI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ALDAVE, ANTHONY JOHN · 2013 to 2017
$1.9M
NEI NIH HHS 1R01 EY022082NEI NIH HHS P30 EY000331NEI NIH HHS R01 EY022082
6 · The paper itself

Abstract

importanceThe identification of steep corneal curvatures in a significant percentage of patients with posterior polymorphous corneal dystrophy (PPCD) confirms this previously reported association and suggests a role for the ZEB1 protein in keratocyte function.

objectiveTo determine whether PPCD is characterized by significant corneal steepening. DESIGN, SETTING, AND

participantsCross-sectional study at university-based and private ophthalmology practices of 38 individuals (27 affected and 11 unaffected) from 23 families with PPCD. EXPOSURE: Slitlamp examination and corneal topographic imaging were performed for individuals with PPCD and unaffected family members. Saliva or blood samples were obtained from each individual for DNA isolation and ZEB1 sequencing. Corneal ZEB1 expression was measured using immunohistochemistry. MAIN OUTCOMES AND MEASURES: Percentage of individuals affected with PPCD and controls with an average keratometric value greater than 48.0 diopters (D) in each eye; the mean keratometric value averaged for both eyes of individuals with PPCD and controls; and the correlation of ZEB1 mutation with keratometric value.

resultsZEB1 coding region mutations were identified in 7 of the 27 affected individuals. Ten of the 38 individuals (26.3%) had average keratometric values greater than 48.0 D OU: 10 of 27 individuals with PPCD (37.0%; 6 of 7 individuals with ZEB1 mutations [85.7%] and 4 of 20 individuals without ZEB1 mutations [20.0%]) and 0 of 11 unaffected individuals (P = .04 for unaffected vs affected individuals; P = .004 for individuals with PPCD with vs without ZEB1 mutation). The mean keratometric value of each eye of affected individuals (48.2 D) was significantly greater than that of each eye of unaffected family members (44.1 D) (P = .03). Affected individuals with ZEB1 mutations demonstrated a mean keratometric value of 53.3 D, which was significantly greater than that of affected individuals without ZEB1 mutations (46.5 D; P = .004). Fluorescence immunohistochemistry demonstrated ZEB1 expression in keratocyte nuclei. CONCLUSIONS AND RELEVANCE: Abnormally steep corneal curvatures are identified in 37% of all individuals with PPCD and 86% of affected individuals with PPCD secondary to ZEB1 mutations. ZEB1 is present in keratocyte nuclei, suggesting a role for ZEB1 in keratocyte function. Therefore, ZEB1 may play a role in both corneal stromal and endothelial development and function, and PPCD should be considered both an endothelial dystrophy and an ectatic disorder.

Indexed as

AdolescentAdultAgedAntigens, CD34ChildCodon, NonsenseCorneaCorneal Dystrophies, HereditaryCorneal KeratocytesCorneal TopographyDilatation, PathologicDNA Mutational AnalysisFemaleFluorescent Antibody Technique, IndirectHomeodomain ProteinsHumansAntigens, CD34Codon, NonsenseHomeodomain ProteinsTranscription FactorsZEB1 protein, humanZinc Finger E-box-Binding Homeobox 1

Identifiers

PMID24113819
PMCPMC3888803
OpenAlexW2120438977

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.